(Q44003021)

28 November 2017

title

Estimation of the contribution of biomarkers of different metabolic pathways to risk of type 2 diabetes (English)

1 reference

28 November 2017

0 references

1 reference

3

1 reference

28 November 2017

7

1 reference

28 November 2017

8

1 reference

28 November 2017

4

Heiner Boeing

1 reference

28 November 2017

Jukka Montonen

1

0 references

Andreas Fritsche

series ordinal

5

object named as

Andreas Fritsche

1 reference

28 November 2017

6

Erwin Schleicher

1 reference

28 November 2017

Dagmar Drogan

2

1 reference

28 November 2017

publication date

28 December 2010

1 reference

European Journal of Epidemiology

28 November 2017

published in

1 reference

28 November 2017

volume

26

1 reference

28 November 2017

issue

1

1 reference

28 November 2017

page(s)

29-38

1 reference

Novel biochemical risk factors for type 2 diabetes: pathogenic insights or prediction possibilities?

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10654-010-9539-0

Liver enzymes and incident diabetes: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-010-9539-0

Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-010-9539-0

Use of multiple metabolic and genetic markers to improve the prediction of type 2 diabetes: the EPIC-Potsdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-010-9539-0

Identifying individuals at high risk for diabetes: The Atherosclerosis Risk in Communities study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-010-9539-0

Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-010-9539-0

Proportion of treatment effect (PTE) explained by a surrogate marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-010-9539-0

Plasma gamma-glutamyltransferase, cysteinyl-glycine, and oxidized low-density lipoprotein: a pathway associated with myocardial infarction risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-010-9539-0

European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-010-9539-0

Reproducibility and relative validity of food group intake in a food frequency questionnaire developed for the German part of the EPIC project. European Prospective Investigation into Cancer and Nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-010-9539-0

Interviewer variability in anthropometric measurements and estimates of body composition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-010-9539-0

Analysis of case-cohort designs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-010-9539-0

Adiponectin and protection against type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-010-9539-0

Adipokines and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-010-9539-0

Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-010-9539-0

Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-010-9539-0

Is serum gamma glutamyltransferase a marker of oxidative stress?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-010-9539-0

Association between glycaemic control and serum lipids profile in type 2 diabetic patients: HbA1c predicts dyslipidaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-010-9539-0

Clinical significance of HbA1c as a marker of circulating lipids in male and female type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-010-9539-0

Poor glycemic control is an independent risk factor for low HDL cholesterol in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-010-9539-0

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-010-9539-0

Genetic variation, C-reactive protein levels, and incidence of diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-010-9539-0

Elevated C-reactive protein is a predictor of the development of diabetes in a general Japanese population: the Hisayama Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-010-9539-0

C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-010-9539-0

Inflammatory markers and risk of developing type 2 diabetes in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-010-9539-0

Elevated C-Reactive Protein Is a Risk Factor for the Development of Type 2 Diabetes in Japanese Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-010-9539-0

Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-010-9539-0

C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-010-9539-0

The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-010-9539-0

Association of serum C-reactive protein level with sex-specific type 2 diabetes risk: a prospective finnish study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-010-9539-0

Association of C-reactive protein with type 2 diabetes: prospective analysis and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-010-9539-0

High glycosylated hemoglobin levels increase the risk of progression to diabetes mellitus in subjects with glucose intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-010-9539-0

A two-step strategy for identification of high-risk subjects for a clinical trial of prevention of NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-010-9539-0

Combined use of fasting plasma glucose and HbA1c predicts the progression to diabetes in Chinese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-010-9539-0

Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-010-9539-0

Reliability of biomarkers of iron status, blood lipids, oxidative stress, vitamin D, C-reactive protein and fructosamine in two Dutch cohorts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-010-9539-0

Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-010-9539-0

Fallibility in estimating direct effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-010-9539-0

Estimation of direct causal effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-010-9539-0

A further critique of the analytic strategy of adjusting for covariates to identify biologic mediation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-010-9539-0

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-010-9539-0

Effects of exercise on adiponectin: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-010-9539-0

Adiponectin: Stability in Plasma over 36 Hours and Within-Person Variation over 1 Year

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-010-9539-0

Recruitment procedures of EPIC-Germany. European Investigation into Cancer and Nutrition

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21188480

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

EPIC-Germany--A source for studies into diet and risk of chronic diseases. European Investigation into Cancer and Nutrition

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21188480

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Glycated haemoglobin predicts progression to diabetes mellitus in Pima Indians with impaired glucose tolerance

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21188480

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S10654-010-9539-0

1 reference

28 November 2017

1 reference